Reenie McCarthy

Reenie McCarthy

Company: President & Chief Executive Officer Stealth BioTherapeutics Inc

Job title: Director

Seminars:

Elamipretide, a Mitochondrial-Targeted Drug, in the Treatment of Dry AMD 3:40 pm

Elamipretide preclinical data showed reversal of AMD pathophysiology & improvement of vision A phase 1 open label safety study of elamipretide in patients with dry AMD showed improvements in multiple measures of vision A phase 2, randomized, double-masked, placebo-controlled clinical study of elamipreide in patients with dry AMD is on-going.Read more

day: Day One

Live Presenter Q&A 5:40 pm

Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.